mRNA: Fulfilling the Promise of Gene Therapy

被引：86

作者：

Weissman, Drew ^{[1
]}

Kariko, Katalin ^{[2
]}

机构：

[1] Univ Penn, Dept Med, Perelman Sch Med, Div Infect Dis, Philadelphia, PA 19104 USA

[2] BioNTech RNA Pharmaceut, D-55131 Mainz, Germany

来源：

MOLECULAR THERAPY | 2015年 / 23卷 / 09期

关键词：

PSEUDOURIDINE; RECOGNITION; MICE;

D O I：

10.1038/mt.2015.138

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

引用

页码：1416 / 1417

页数：2

共 12 条

[1] Nucleic acid agonists for toll-like receptor 7 are defined by the presence of uridine ribonucleotides [J].

Diebold, Sandra S. ;

Massacrier, Catherine ;

Akira, Shizuo ;

Paturel, Carine ;

Morel, Yannis ;

Sousa, Caetano Reis e .

EUROPEAN JOURNAL OF IMMUNOLOGY, 2006, 36 (12) :3256-3267

[2] Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8 [J].

Heil, F ;

Hemmi, H ;

Hochrein, H ;

Ampenberger, F ;

Kirschning, C ;

Akira, S ;

Lipford, G ;

Wagner, H ;

Bauer, S .

SCIENCE, 2004, 303 (5663) :1526-1529

[3] REVERSAL OF DIABETES-INSIPIDUS IN BRATTLEBORO RATS - INTRAHYPOTHALAMIC INJECTION OF VASOPRESSIN MESSENGER-RNA [J].

JIRIKOWSKI, GF ;

SANNA, PP ;

MACIEJEWSKILENOIR, D ;

BLOOM, FE .

SCIENCE, 1992, 255 (5047) :996-998

[4] Suppression of RNA recognition by Toll-like receptors:: The impact of nucleoside modification and the evolutionary origin of RNA [J].

Karikó, K ;

Buckstein, M ;

Ni, HP ;

Weissman, D .

IMMUNITY, 2005, 23 (02) :165-175

[5] Incorporation of Pseudouridine Into mRNA Yields Superior Nonimmunogenic Vector With Increased Translational Capacity and Biological Stability [J].

Kariko, Katalin ;

Muramatsu, Hiromi ;

Welsh, Frank A. ;

Ludwig, Janos ;

Kato, Hiroki ;

Akira, Shizuo ;

Weissman, Drew .

MOLECULAR THERAPY, 2008, 16 (11) :1833-1840

[6] Increased Erythropoiesis in Mice Injected With Submicrogram Quantities of Pseudouridine-containing mRNA Encoding Erythropoietin [J].

Kariko, Katalin ;

Muramatsu, Hiromi ;

Keller, Jason M. ;

Weissman, Drew .

MOLECULAR THERAPY, 2012, 20 (05) :948-953

[7] Generating the optimal mRNA for therapy: HPLC purification eliminates immune activation and improves translation of nucleoside-modified, protein-encoding mRNA [J].

Kariko, Katalin ;

Muramatsu, Hiromi ;

Ludwig, Janos ;

Weissman, Drew .

NUCLEIC ACIDS RESEARCH, 2011, 39 (21) :e142

[8] Expression of therapeutic proteins after delivery of chemically modified mRNA in mice [J].

Kormann, Michael S. D. ;

Hasenpusch, Guenther ;

Aneja, Manish K. ;

Nica, Gabriela ;

Flemmer, Andreas W. ;

Herber-Jonat, Susanne ;

Huppmann, Marceline ;

Mays, Lauren E. ;

Illenyi, Marta ;

Schams, Andrea ;

Griese, Matthias ;

Bittmann, Iris ;

Handgretinger, Rupert ;

Hartl, Dominik ;

Rosenecker, Joseph ;

Rudolph, Carsten .

NATURE BIOTECHNOLOGY, 2011, 29 (02) :154-U96

[9] Cutting edge:: Innate immune system discriminates between RNA containing bacterial versus eukaryotic structural features that prime for high-level IL-12 secretion by dendritic cells [J].

Koski, GK ;

Karikó, K ;

Xu, SW ;

Weissman, D ;

Cohen, PA ;

Czerniecki, B .

JOURNAL OF IMMUNOLOGY, 2004, 172 (07) :3989-3993

[10] mRNA-based therapeutics - developing a new class of drugs [J].

Sahin, Ugur ;

Kariko, Katalin ;

Tuereci, Oezlem .

NATURE REVIEWS DRUG DISCOVERY, 2014, 13 (10) :759-780

← 1 2 →